Rowe DB - Search Results

1

Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.

Dzamko N, Chua G, Ranola M, Rowe DB, Halliday GM. Dzamko N, et al. Among authors: rowe db. J Parkinsons Dis. 2013;3(2):145-52. doi: 10.3233/JPD-130174. J Parkinsons Dis. 2013. PMID: 23938344

2

An inflammatory review of Parkinson's disease.

Orr CF, Rowe DB, Halliday GM. Orr CF, et al. Among authors: rowe db. Prog Neurobiol. 2002 Dec;68(5):325-40. doi: 10.1016/s0301-0082(02)00127-2. Prog Neurobiol. 2002. PMID: 12531233 Review.

3

Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test.

Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM. Double KL, et al. Among authors: rowe db. Arch Neurol. 2003 Apr;60(4):545-9. doi: 10.1001/archneur.60.4.545. Arch Neurol. 2003. PMID: 12707068

4

Genetic contributions to Parkinson's disease.

Huang Y, Cheung L, Rowe D, Halliday G. Huang Y, et al. Brain Res Brain Res Rev. 2004 Aug;46(1):44-70. doi: 10.1016/j.brainresrev.2004.04.007. Brain Res Brain Res Rev. 2004. PMID: 15297154 Review.

5

A possible role for humoral immunity in the pathogenesis of Parkinson's disease.

Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM. Orr CF, et al. Among authors: rowe db. Brain. 2005 Nov;128(Pt 11):2665-74. doi: 10.1093/brain/awh625. Epub 2005 Oct 11. Brain. 2005. PMID: 16219675

6

Anticipation of onset age in familial Parkinson's disease without SCA gene mutations.

Huang Y, Hayes M, Harding AJ, Brooks WS, Fung VS, Rowe D, Joffe R, Crimmins D, Hely M, Halliday GM. Huang Y, et al. Parkinsonism Relat Disord. 2006 Jun;12(5):309-13. doi: 10.1016/j.parkreldis.2006.01.002. Epub 2006 Apr 18. Parkinsonism Relat Disord. 2006. PMID: 16621662 Clinical Trial.

7

A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.

Sutherland G, Mellick G, Sue C, Chan DK, Rowe D, Silburn P, Halliday G. Sutherland G, et al. Neurosci Lett. 2007 Mar 6;414(2):170-3. doi: 10.1016/j.neulet.2006.12.051. Epub 2007 Jan 7. Neurosci Lett. 2007. PMID: 17280783

8

Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.

Huang Y, Halliday GM, Vandebona H, Mellick GD, Mastaglia F, Stevens J, Kwok J, Garlepp M, Silburn PA, Horne MK, Kotschet K, Venn A, Rowe DB, Rubio JP, Sue CM. Huang Y, et al. Among authors: rowe db. Mov Disord. 2007 May 15;22(7):982-9. doi: 10.1002/mds.21477. Mov Disord. 2007. PMID: 17427941

9

Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease.

Sutherland G, Mellick G, Newman J, Double KL, Stevens J, Lee L, Rowe D, Silburn P, Halliday GM. Sutherland G, et al. Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):495-9. doi: 10.1002/ajmg.b.30633. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18085551 Free article.

10

Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community.

Mehta P, Mellick GD, Rowe DB, Halliday GM, Jones MM, Manwaring N, Vandebona H, Silburn PA, Wang JJ, Mitchell P, Sue CM. Mehta P, et al. Among authors: rowe db. Mov Disord. 2009 Jan 30;24(2):290-2. doi: 10.1002/mds.22389. Mov Disord. 2009. PMID: 19086081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters